HIV is associated with thrombophilia and high D-dimer in children and adolescents

AIDS

Volumn 24, Issue 8, 2010, Pages 1145-1151

  Pontrelli, Giuseppe ^a   Martino, Alessandra M ^a   Tchidjou, Hyppolite K ^a   Citton, Rita ^a   Mora, Nadia ^a   Ravà, Lucilla ^b   Tozzi, Alberto E ^b   Palma, Paolo ^a   Muraca, Maurizio ^c   Franco, Elisabetta ^a   Rossi, Paolo ^a   Bernardi, Stefania ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Department of Ospedale Pediatrico Bambino Gesù ^*  (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

D dimer; HIV; Paediatric; Protein S; Thrombophilia

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ANTITHROMBIN; C REACTIVE PROTEIN; D DIMER; DIDANOSINE; FIBRINOGEN; HOMOCYSTEINE; PROTEIN C; PROTEIN S; PROTEINASE INHIBITOR; VIRUS RNA;

ADOLESCENT; ANTITHROMBIN DEFICIENCY; ARTICLE; BLOOD CLOTTING DISORDER; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOPHILIA; VIRUS LOAD; VIRUS REPLICATION;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; ANTIFIBRINOLYTIC AGENTS; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; THROMBOPHILIA; VIRAL LOAD; VIRUS REPLICATION;

EID: 77951804888     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328337b9a0     Document Type: Article

References (39)

1. d'Arminio Monforte A, Sabin CA, Phillips A, Sterne J, May M, Justice A, et al. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arc Intern Med 2005; 165:416-423. (Pubitemid 40280197)
2. Chiappini E, Galli L, Tovo PA, Gabiano C, Lisi C, Castelli Gattinara G, et al. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART. AIDS 2007; 21:1607-1615. (Pubitemid 47075482)
3. Calza L, Manfredi R, Pocaterra D, Chiodo F. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy. J Infect 2008; 57:16-32.
4. McComsey GA, O'Riordan M, Hazen SL, El-Bejjani D, Bhatt S, Brennan ML, et al. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 2007; 21:921-927. (Pubitemid 46684323)
5. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338:1650-1656. (Pubitemid 28267909)
6. D:A:D Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349: 1993-2003.
7. D:A:D Study Group. Class of antiretroviral drugs and the risk for myocardial infarction. N Engl J Med 2007; 356:1723-1735. (Pubitemid 46658704)
8. D:A:D Study Group. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multicohort collaboration. Lancet 2008; 371:1417-1426.
9. Bedimo R, Westfall A, Drechsler H, Tebas P. Abacavir use and risk of acute myocardial infarction and cerebrovascular disease in the HAART era. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. July 19-22, 2009. Cape Town. Abstract MOAB202.
10. Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4R count-guided interruption of antiretrovir-al treatment. N Engl J Med 2006; 355:2283-2296.
11. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS 2008; 22:2409-2418.
12. INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:1496-1508.
13. Lijfering WM, Sprenger HG, Georg RR, van der Meulen PA, van der Meer J. Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection. Clin Chem 2008; 54:1226-1233. (Pubitemid 352009700)
14. Levine AM, VigenC,GravinkJ,MackW,Watts H, Liebman HA. Progressive prothrombotic state in women with advancing HIV disease. J Acquir Immune Defic Syndr 2006; 42:572-577.
15. Sullivan PS, Dworkin MS, Jones JL, Hooper WC. Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project. AIDS 2000; 14:321-324.
16. Berruyer M, Causse X, Dechavanne M, Trepo C. Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1992; 5:484-489.
17. Hassell KL, Kressin DC, Neumann A, Ellison R, Marlar RA. Correlation of antiphospholipid antibodies and protein S deficiency with thrombosis in HIV-infected men. Blood Coagul Fibrinolysis 1994; 5:455-462. (Pubitemid 24301563)
18. Fultz SL, McGinnis KA, Skanderson M, Ragni MV, Justice AC. Associationofvenous thromboembolism with human immunodeficiency virus and mortality in veterans. Am J Med 2004; 116:420-423. (Pubitemid 38299488)
19. Erbe M, Rickerts V, Bauersachs RM, Lindhoff-Last E. Acquired protein C and protein S deficiency in HIV-infected patients. Clin Appl Thromb Hemost 2003; 9:325-331. (Pubitemid 37414123)
20. Sugerman RW, Church JA, Goldsmith JC, Ens GE. Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1996; 15:106-111. (Pubitemid 26066488)
21. CDC 1993. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993; 41 (No RR-17).
22. CDC. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR 1987; 36:225-230, 235.
23. Jansen J, Lijfering WM, Sprenger H, van der Meer J, van Pampus M. Venous thromboembolism in HIV-positive women during puerperium: a case series. Blood Coagul Fibrinolysis 2008; 19:95-97
24. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of anti-retroviral agents in pediatric HIV infection. February 23, 2009; 1-139. Available at http://aidsinfo.nih.gov/ContentFiles/Pedia-tricGuidelines.pdf.
25. Palma P, Romiti ML, Cancrini C, Pensieroso S, Montesano C, Santucci MB, et al. Successful simplification of protease inhibitor-based HAART with triple nucleoside regimens in children vertically infected with HIV. AIDS 2007; 21:2465-2472. (Pubitemid 350145178)
26. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348:1435-1441. (Pubitemid 36407172)
27. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117:93-102. (Pubitemid 350301144)
28. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353:1167-1173.
29. Mahmoodi BK, Brouwer JLP, Veeger NJ, van der Meer J. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age, results from a large family cohort study. Circulation 2008; 118:1659-1667.
30. Levi M, Keller TT, van Gorp E, ten Cate H. Infection and inflammation and coagulation system. Cardiovasc Res 2003; 60:26-69.
31. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-1143. (Pubitemid 34212626)
32. Esmon CT. Inflammation and thrombosis. J Thromb Haemost 2003; 1:1343-1348.
33. Lafon ME, Steffan AM, Royer C, et al. HIV-1 infection induces functional alterations in human liver endothelial cells in primary culture. AIDS 1994; 8:747-752. (Pubitemid 24163415)
34. Hooper WC, Phillips DJ, Ribeiro MJ, Benson JM, George VG, Ades EW, et al. Tumor necrosis factor alpha downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HepG-2 hepatoma cell line. Blood 1994; 84:483-489. (Pubitemid 2110436)
35. Bergamini A, Faggioli E, Bolacchi F, Gessani S, Capannoni L, Uccella I, et al. Enhanced production of tumor necrosis factor alpha and interleukin-6 due to prolonged response to lipopo-lysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1. J Infect Dis 1999; 179:832-842. (Pubitemid 29159328)
36. Schecter AD, Berman AB, Yi L, Mosoian A, McManus CM, Berman JW, et al. HIV envelope gp120 activates human arterial smooth muscle cells. Proc Natl Acad Sci USA 2001; 98:10142-10147. (Pubitemid 32802988)
37. Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood 1993; 81:1801-1807. (Pubitemid 23101593)
38. de Larranaga G, Pere s S, Puga L, Alonso B, Benetucci J. Association between the acquired free protein S deficiency in HIV infected patients with the lipid profile levels. J Thromb Haemost 2004; 2:1195-1197.
39. Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000; 53:573-580.